H2AX and inflammatory bowel disease: We did not find significant differences either between dysplasic and hyperplastic polyps or within IBD pathologies although H2AX phosphorylation levels doubled in CD (0.49 ± 1.17%) with respect to UC (0.24 ± 0.05%) (data not shown).